Seal Rock Therapeutics Collaborates with MJFF's LITE Program to Develop LRRK2 Therapies for Parkinson's Disease Seal Rock Therapeutics is joining forces with The Michael J. Fox Foundation's LITE program to advance innovative therapies targeting LRRK2 for Parkinson's disease.

Seal Rock Therapeutics Collaborates with MJFF's LITE Program to Develop LRRK2 Therapies for Parkinson's Disease #USA #Seattle #Parkinson's_Disease #Seal_Rock #LRRK2